ZA885101B - Human granulocyte macrophage colony stimulating factor and muteins thereof - Google Patents

Human granulocyte macrophage colony stimulating factor and muteins thereof

Info

Publication number
ZA885101B
ZA885101B ZA885101A ZA885101A ZA885101B ZA 885101 B ZA885101 B ZA 885101B ZA 885101 A ZA885101 A ZA 885101A ZA 885101 A ZA885101 A ZA 885101A ZA 885101 B ZA885101 B ZA 885101B
Authority
ZA
South Africa
Prior art keywords
muteins
stimulating factor
colony stimulating
macrophage colony
human granulocyte
Prior art date
Application number
ZA885101A
Other languages
English (en)
Inventor
Takashi Yokota
Yokota Takashi
Frank D Lee
D Lee Frank
Donna M Rennick
M Rennick Donna
Ken-Ichi Arai
Arai Ken-Ichi
Naoko Arai
Arai Naoko
Original Assignee
Schering Biotech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Biotech Corp filed Critical Schering Biotech Corp
Publication of ZA885101B publication Critical patent/ZA885101B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/53Colony-stimulating factor [CSF]
    • C07K14/535Granulocyte CSF; Granulocyte-macrophage CSF
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Saccharide Compounds (AREA)
ZA885101A 1987-07-17 1988-07-14 Human granulocyte macrophage colony stimulating factor and muteins thereof ZA885101B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7498887A 1987-07-17 1987-07-17

Publications (1)

Publication Number Publication Date
ZA885101B true ZA885101B (en) 1989-03-29

Family

ID=22122850

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA885101A ZA885101B (en) 1987-07-17 1988-07-14 Human granulocyte macrophage colony stimulating factor and muteins thereof

Country Status (14)

Country Link
EP (2) EP0370052A1 (ja)
JP (2) JPH082310B2 (ja)
KR (1) KR970002212B1 (ja)
AT (1) ATE87973T1 (ja)
CA (1) CA1335717C (ja)
DE (1) DE3880032T2 (ja)
DK (1) DK12990A (ja)
ES (1) ES2039624T3 (ja)
IE (1) IE63514B1 (ja)
IL (1) IL87119A0 (ja)
MY (1) MY103542A (ja)
NZ (1) NZ225411A (ja)
WO (1) WO1989000582A2 (ja)
ZA (1) ZA885101B (ja)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2428132A (en) * 1946-01-21 1947-09-30 James C Waldo Dispenser for sticklike articles
US6254861B1 (en) 1989-05-23 2001-07-03 Chandra Choudhury Hematopoietic growth factor derived from T lymphocytes
WO1990014351A1 (en) * 1989-05-23 1990-11-29 Chandra Choudhury Hematopoietic growth factor derived form t lymphocytes and methods of use therefor
JPH04148687A (ja) * 1990-10-09 1992-05-21 Asahi Chem Ind Co Ltd M―csf活性ポリペプチドの安定的高発現組換えベクター
EP0557420A1 (en) * 1990-11-16 1993-09-01 Schering Corporation Method for inducing maturation of myeloid cells with interleukin-5
GB9120304D0 (en) * 1991-09-24 1991-11-06 Erba Carlo Spa Stable pharmaceutical compositions containing a granulocyte macrophage colony stimulating factor
US5255873A (en) * 1992-10-19 1993-10-26 Nelson Robert L Flying wing space launch assist stage
US6100070A (en) * 1995-10-05 2000-08-08 G. D. Searle & Co. G-CSF receptor agonists
EP0859843A1 (en) * 1995-10-05 1998-08-26 G.D. Searle & Co. Novel g-csf receptor agonists
AU5921098A (en) * 1997-01-16 1998-08-07 Human Genome Sciences, Inc. Hematopoietic signaling factor
JP2007135248A (ja) * 2001-10-26 2007-05-31 Fujitsu Ltd 圧電薄膜共振子およびフィルタ
DE102010033515A1 (de) 2010-08-05 2012-02-09 Gm Global Technology Operations Llc (N.D.Ges.D. Staates Delaware) Vorrichtung und Verfahren zum Vermeiden des Eindringens von Fremdpartikeln in einen Fahrzeuginnenraum
JP7033846B2 (ja) * 2016-12-06 2022-03-11 ローム株式会社 圧電素子

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE60819B1 (en) * 1984-07-06 1994-08-10 Sandoz Ltd Lymphokine production and purification
PT81513B (pt) * 1984-11-20 1988-03-03 Schering Biotech Corp Clones de dna codificando polipeptideos que apresentam actividade de factor de crescimento celular para granulocitos, madrofagos e eosinofilos humanos
JPS63502795A (ja) * 1985-10-03 1988-10-20 バイオジェン インコーポレイテッド 顆粒球‐マクロファージコロニー刺激因子‐様ポリペプチド、dna配列、組換えdna分子並びに微生物細胞中でヒト顆粒球−マクロファ−ジコロニ−刺激因子−様ポリペプチドを高収量で生産する方法

Also Published As

Publication number Publication date
JPH02502877A (ja) 1990-09-13
EP0299782A2 (en) 1989-01-18
WO1989000582A2 (en) 1989-01-26
DK12990D0 (da) 1990-01-16
KR890701627A (ko) 1989-12-21
EP0299782B1 (en) 1993-04-07
IL87119A0 (en) 1988-12-30
NZ225411A (en) 1991-04-26
DK12990A (da) 1990-03-16
KR970002212B1 (ko) 1997-02-25
ATE87973T1 (de) 1993-04-15
DE3880032T2 (de) 1993-08-19
DE3880032D1 (de) 1993-05-13
EP0299782A3 (en) 1989-08-09
EP0370052A1 (en) 1990-05-30
IE882147L (en) 1989-01-17
ES2039624T3 (es) 1993-10-01
WO1989000582A3 (en) 1989-02-23
IE63514B1 (en) 1995-05-03
JPH082310B2 (ja) 1996-01-17
JPH1052280A (ja) 1998-02-24
CA1335717C (en) 1995-05-30
MY103542A (en) 1993-07-31

Similar Documents

Publication Publication Date Title
MY102806A (en) Human interleukin-3 and muteins thereof
EP0299782A3 (en) Human granulocyte macrophage colony stimulating factor and muteins thereof
EP0272779A3 (en) New forms of colony stimulating factor-1
FI953593A (fi) G-CSF-analogikoostumuksia ja menetelmiä
AU596997C (en) Pharmaceutical composition for the treatment of leukopenia
EP0230980A3 (en) Pharmaceutical agent for promoting the recovery of hemopoietic capacity
DE3061854D1 (en) Process for the preparation of interferon and culture medium composition used in it
ZA924674B (en) Cysteine depleted il-6 mutein
EP0231819A3 (en) Pharmaceutical agent for the treatment of myelogenous leukemia
IL84080A0 (en) Human leukocyte interferon compositions for skin treatment
Gerhartz et al. Cloning of early erythroid and mixed myeloid/erythroid human bone marrow progenitor cells: comparison of different sources of burst-promoting activity (BPA)
IL66535A0 (en) Aerobic method for preserving whole blood,tissue and components containing living mammalian cells